Apollo KKR Close Bayer LARC Capital Solution
Analysis based on 7 articles · First reported Sep 16, 2026 · Last updated Sep 16, 2026
The closing of the 3 billion euro capital solution provides Bayer with balance-sheet relief and improved financial flexibility, which is modestly positive for Bayer credit and equity sentiment while signaling continued sponsor appetite for large German blue-chip capital solutions. For Apollo and KKR & Co., the deal reinforces their private capital deployment pipelines and fee-generating asset growth, a mildly supportive signal for alternative asset managers.
Apollo Global Management announced on September 16, 2026 that Apollo-managed funds and affiliates closed a 3 billion euro capital solution for Bayer, a transaction first announced on July 10, 2026. KKR & Co. joined Apollo as a significant minority participant in the investment, a detail not disclosed in Bayer's original July announcement. Under the transaction, Apollo and KKR & Co. invested equity capital into a newly established entity holding Bayer's long-acting reversible contraceptives (LARC) business. Bayer retains a majority stake in the entity and continues to exercise full operational control over the business, with no changes to the LARC strategy. The LARC activities remain part of the Bayer Pharmaceuticals Division and the entity stays fully consolidated in Bayer's financial statements. Bayer CFO Judith Hartmann said in July that the transaction strengthens the company's capital structure while preserving operational control, and enhances financial flexibility amid increased liquidity requirements related to bond maturities and litigation. Apollo Partner Jamshid Ehsani said Apollo has committed to deploying more than 100 billion dollars in Germany over the coming decade. Bayer was advised by Bank of America and Deutsche Bank as financial advisors and by Linklaters as legal advisor. Centerview Partners advised the Apollo funds, with Latham & Watkins, Paul, Weiss, Rifkind, Wharton & Garrison, and NautaDutilh as legal counsel. The deal was subject to antitrust approval and closed within the expected third quarter of 2026 window.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard